Author name: DrugChatter

Brand vs Brand: the confusion suite Drug switching is supposed to be boring: swap one product for another and keep […]

Patients rarely ask “what’s dangerous?” in the abstract. They ask it the way you’d ask about traffic: Is this normal?

The Short Answer Veeva Systems is running two parallel agentic AI programs in drug safety at once, and they are

There are only so many ways a question can start: “Can I stop taking…”—and then the name of a drug

There are two kinds of medication mistakes: the ones that happen because the label is complicated, and the ones that

Here’s a recurring scene in clinics and pharmacies: someone reads their prescription label, nods along with a meaning that feels

There’s a special kind of dread that comes with a prescription that’s framed like a lifestyle choice. You don’t just

There’s a special kind of medication mistake that doesn’t feel like a mistake at all. It feels like “being thorough.”

A compliance primer for Medical Affairs, Regulatory Affairs, Pharmacovigilance, and Brand teams The Short Answer Neither FDA nor EMA has

Real Chemistry billed HealthGEO, launched on August 21, 2025, as the industry’s first healthcare-specific generative engine optimization (GEO) intelligence platform

Switching drugs can be bewildering—especially when the prescriptions look different but the clinician says (or the label implies) it’s “the

By 2002, an estimated 94% of gabapentin prescriptions were written for conditions the drug was never approved to treat [6].